GW PHARMACEUTICALS PLC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$115.3M

660 transactions

Summary

GW PHARMACEUTICALS PLC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $49KSales: $101.9M16 insiders

Date	Insider	Type	Value
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Waldegrave William A.	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Brown Cabot	D	—
2021-05-05	Gover Justin D.(Chief Executive Officer)	D	—
2021-05-05	Gover Justin D.(Chief Executive Officer)	D	—
2021-05-05	Gover Justin D.(Chief Executive Officer)	D	—
2021-05-05	Gover Justin D.(Chief Executive Officer)	D	—
2021-05-05	Gover Justin D.(Chief Executive Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

GW PHARMACEUTICALS PLC — Contributions, Lobbying & Contracts | Poliscope